Woodline Partners LP - ATEA PHARMACEUTICALS INC ownership

ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 128 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.

Quarter-by-quarter ownership
Woodline Partners LP ownership history of ATEA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$1,863,000
-71.3%
208,399
+12.5%
0.03%
-74.5%
Q3 2021$6,495,000
+61.0%
185,265
-1.4%
0.11%
+41.3%
Q2 2021$4,034,000
-69.7%
187,805
-12.9%
0.08%
-74.6%
Q1 2021$13,318,000
+15.5%
215,673
-21.9%
0.30%
-3.6%
Q4 2020$11,535,000276,0830.31%
Other shareholders
ATEA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Tyrus Capital S.A.M. 1,260,000$3,780,00035.90%
BML Capital Management, LLC 4,800,000$14,400,00013.22%
Stonepine Capital Management, LLC 1,720,000$5,160,0001.71%
TANG CAPITAL MANAGEMENT LLC 3,600,000$10,800,0001.52%
CM Management, LLC 275,000$825,0000.88%
Bain Capital Life Sciences Investors, LLC 2,485,638$7,456,9140.83%
EcoR1 Capital, LLC 6,995,861$20,987,5830.71%
SECTORAL ASSET MANAGEMENT INC 600,461$1,801,3830.35%
Newtyn Management, LLC 400,000$1,200,0000.30%
Diametric Capital, LP 200,000$600,0000.25%
View complete list of ATEA PHARMACEUTICALS INC shareholders